Fish vaccination: choosing a route that fits the stock

Vaccination is central to disease prevention in aquaculture, but “vaccinating a stock” is not one standard procedure. Individual injection, group immersion and antigen delivered with feed expose different tissues and create different operational uncertainties. The fastest or least expensive option is therefore not automatically the right one. Selection must begin with the authorised veterinary medicine, then account for species, size, health, infection risk and the farm’s ability to perform the procedure consistently.

Start with the authorised product

The product information defines the target species, indication, route, dose, minimum age or weight, storage, onset of immunity and precautions. An injectable formulation does not become an immersion vaccine because dilution looks convenient. A bath vaccine must not be injected. Antigen concentration, excipients and safety evidence were assessed for a specified use.

The European Medicines Agency guideline revised for July 2026 requires studies matched to the proposed species, route and conditions of use. Efficacy should rely on a relevant challenge; safety should address local and systemic reactions; and duration of protection should be supported. The same discipline helps practitioners separate evidence for the product in hand from results obtained with a different formulation.

Injection: defined delivery with a handling burden

Injection provides a defined amount to each fish and is often selected when a strong systemic response is sought in fish large enough to handle. Multivalent products can combine antigens. Precision comes with biological and logistical costs: fasting where required, capture, anaesthesia, restraint, correct needle placement and recovery all need planning.

Poor injection site, inappropriate needles, excessive throughput or weak hygiene can increase injury and secondary infection. Some adjuvanted products cause local reactions or adhesions, with severity depending on formulation and technique. Staff need training and protection from accidental self-injection, and the line must stop if accuracy deteriorates. Post-vaccination sampling can assess reactions and performance instead of relying on mortality alone.

Immersion: group treatment without identical exposure

Immersion is valuable for small fish for which injection would impose disproportionate handling. Mucosal surfaces, including gills and skin, meet antigen during a defined bath. Because the operation is collective, bath concentration, biomass, water quality, oxygen, temperature and exposure time require documentation.

Collective does not mean uniform. Weak fish, size variation, residual flow or poor mixing can alter exposure. Transfer into and out of the bath adds stress. Facilities should match water volume to biomass, monitor behaviour and provide suitable recovery water. Stocks experiencing clinical disease, hypoxia or thermal stress should not be processed without veterinary assessment.

Oral delivery: attractive, but governed by intake

Oral vaccination avoids individual capture and can be attractive for boosters. It presents specific barriers: preserving antigen during manufacture and storage, limiting digestive degradation, crossing the intestinal barrier and ensuring consumption. Feeding hierarchy, appetite, pellet size and losses to water make individual exposure less predictable.

Scientific reviews describe encapsulation and vector approaches, but variable results do not make formulations interchangeable. Detecting an immune response after feeding does not by itself prove durable clinical protection. On farm, oral vaccination still requires an authorised product and defined protocol, with feed distribution and consumption recorded.

Use a decision matrix

First define the disease problem: relevant pathogen, circulating strain, expected season and the window needed for immunity. Then assess fish and stock: species, stage, size, health history, recent treatments and uniformity. Finally assess capacity: trained people, anaesthesia, bath tanks, backup oxygen, cold chain and traceability.

Temperature affects metabolism, immune development, handling tolerance and the time needed to establish protection. Degree-day statements in product documents cannot be converted into a fixed calendar date while ignoring specified temperature limits. Vaccination should also precede transfer or anticipated exposure by an adequate margin.

The route may change as the production cycle progresses. Small juveniles may receive immersion under a labelled programme, while an authorised injectable product is used later. An oral booster may fit another risk period. Such sequences are valid only when supported by the relevant labels and veterinary plan, not because each route appears separately in the literature.

Record execution, not merely outcome

Useful records also make comparison possible across cohorts. They show whether apparent protection changed with size, water temperature or operator, while preventing a convenient but unsupported explanation after disease occurs. Any comparison still needs diagnostic confirmation and awareness that pathogen pressure may differ between cohorts.

A campaign record should connect fish lot and vaccine batch with date, temperature, biomass, route, operators and incidents. Injection records can include placement checks and local reactions. Immersion records need concentration, volume, time and oxygen. Oral programmes need ration, duration, refusals and delivery conditions.

Later mortality is not automatically “vaccine failure”. Diagnosis must confirm the agent, consider a strain outside expected coverage, verify time since vaccination and examine environmental conditions. Vaccination complements biosecurity, water quality, surveillance and diagnosis; it cannot replace them.

Vetofish can support route selection, campaign audits and investigation of post-vaccination disease alongside the farm veterinarian. The defensible route is the one the product permits, the fish can tolerate and the team can deliver reproducibly.